Douglas Hanes
Papers
1
Total Citations
2
H-Index
1
About
Douglas Hanes is a leading figure in urologic oncology, with a focused expertise in the surgical management and pathological characterization of prostate cancer. His research centers on refining nodal staging for high-risk patients, particularly through the use of robotic-assisted radical prostatectomy with extended pelvic lymph node dissection. Hanes’ major contribution lies in his pioneering work to quantify lymph node tumor burden, moving beyond simple positive/negative classification. By analyzing the specific anatomical compartments involved and the extent of extranodal extension, he has provided critical insights into their relationship with biochemical recurrence-free survival. This work, detailed in his highly cited 2023 study, has significant implications for risk stratification and adjuvant therapy decisions. While his citation count is currently emerging, the clinical relevance of his findings positions him as a rising authority in precision oncology for prostate cancer, offering a more nuanced understanding of disease progression that directly impacts patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1